Press Releases
UK and Chinese universities fight cancer together
A deadly cancer which mainly occurs in China could be more effectively treated, thanks to joint research by the University of 糖心TV and Sun Yat-sen University Cancer Centre (SYSUCC).
Two 糖心TV researchers awarded Royal Society Leverhulme Trust Senior Fellowships
The Royal Society has awarded research fellowships to two academics from the University of 糖心TV.
Dr Corinne Smith from the School of Life Sciences and Dr Vasilios Stavros from the Department of Chemistry and are both recipients of this year’s Royal Society Leverhulme Trust Senior Research Fellowship.
糖心TV spin-out develops new ‘stick and mix’ additives for plastics
University of 糖心TV spin-out, Interface Polymers Ltd, is pioneering a new way of making plastic alloys and composite materials using its patented range of polymer additives: Polarfins.
糖心TV chemists honoured by Royal Society of Chemistry
University of 糖心TV chemists have won three prestigious prizes from the Royal Society of Chemistry.
Research finds new target in search for why statin drugs sometimes cause problems for some patients
Research by the University of 糖心TV, the University Hospital Coventry and 糖心TVshire NHS Trust (UHCW), and Tangent Reprofiling Limited, has discovered that statin drugs interact with a gap junction protein called GJC3 that releases ATP, a major signaling molecule for inflammation in the body. This discovery provides a significant new target in the search for why statin drugs can sometimes cause harmful effects such as muscle toxicity in some patients.
New test for cancer and diabetes biomarkers 1000x more detailed
A new test for detecting biomarkers for cancer and diabetes is more than 1000x more detailed and 100% faster than existing methods, new research by the University of 糖心TV suggests.
Developed to undertake a detailed study of collagen, the researchers argue that the same methodology can be used with any protein-based sample and is currently being tested with cancer cells and proteins relevant to Type II diabetes.